Infection and Drug Resistance
Scope & Guideline
Illuminating the path to effective therapeutic interventions.
Introduction
Aims and Scopes
- Antimicrobial Resistance Mechanisms:
Research on the genetic and phenotypic mechanisms of antimicrobial resistance in various pathogens, including bacteria, fungi, and viruses, is a primary focus, aiming to elucidate the pathways through which resistance develops and spreads. - Infectious Disease Epidemiology:
The journal publishes studies that analyze the epidemiological trends of infectious diseases, including their transmission dynamics, risk factors, and the impact of social and environmental determinants on disease outbreaks. - Clinical Outcomes and Treatment Strategies:
Articles explore clinical outcomes associated with different treatment regimens for infections, particularly those caused by multidrug-resistant organisms, and evaluate the efficacy and safety of novel therapeutic agents. - Diagnostic Innovations:
There is a strong focus on the development and validation of new diagnostic methods, including molecular techniques such as metagenomic next-generation sequencing, aimed at improving the speed and accuracy of pathogen identification. - Public Health Interventions:
The journal highlights studies on public health interventions and strategies for infection prevention and control, particularly in healthcare settings, to mitigate the impact of drug-resistant infections. - Global Health Perspectives:
Research articles often incorporate global health perspectives, addressing the challenges of infectious diseases and antimicrobial resistance in various geographical and socio-economic contexts.
Trending and Emerging
- Metagenomic Approaches:
There is a rising trend in the application of metagenomic next-generation sequencing for diagnosing complex infections, allowing for a more comprehensive understanding of microbial communities and resistance profiles. - Machine Learning and AI in Infectious Diseases:
The integration of machine learning and artificial intelligence in predicting infection outcomes and resistance patterns is gaining traction, with studies exploring how these technologies can enhance clinical decision-making. - Impact of COVID-19 on Other Infections:
Research examining the impact of the COVID-19 pandemic on the epidemiology and management of other infectious diseases, including the resurgence of previously controlled infections, is increasingly relevant. - Vaccination Strategies and Acceptance:
With the ongoing vaccination efforts against COVID-19 and other infectious diseases, research on vaccine uptake, acceptance, and the associated factors is becoming a significant focus area. - One Health Approach:
The journal is increasingly publishing articles that adopt a One Health perspective, addressing the interconnectedness of human, animal, and environmental health in the context of infectious diseases and antimicrobial resistance. - Public Health Strategies for Infection Control:
There is a growing emphasis on evaluating and developing public health strategies and interventions for infection prevention and control, particularly in healthcare settings and during outbreaks.
Declining or Waning
- Traditional Antibiotic Approaches:
Research focusing solely on conventional antibiotic therapies without considering resistance mechanisms or the need for combination therapies has declined as the field shifts towards more integrated approaches to combat resistance. - Single-Agent Studies:
Studies evaluating the efficacy of single-agent antibiotic therapies have become less frequent as the understanding of polymicrobial infections and the need for combination therapies gains prominence. - Basic Laboratory Research:
There is a noticeable decline in purely basic laboratory studies that do not translate into clinical relevance or application, as the journal increasingly prioritizes translational research with direct implications for patient care. - Historical Epidemiological Data:
Research that focuses solely on historical epidemiological data without providing insights into current trends or implications for practice appears to be waning, reflecting a shift towards real-time data analysis and its application in public health.
Similar Journals
CLINICAL MICROBIOLOGY AND INFECTION
Pioneering Research in Infectious DiseasesCLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.
International Journal of Antimicrobial Agents
Transforming Knowledge into Practice for Better Patient OutcomesInternational Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.
ACS Infectious Diseases
Cutting-edge Research for a Healthier TomorrowACS Infectious Diseases is a premier journal in the field of infectious diseases, published by the American Chemical Society. With an impressive Impact Factor that places it in the Q1 category for Infectious Diseases in 2023, the journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of infectious agents and their impact on public health. Established in 2015, the journal is committed to publishing cutting-edge research that enhances our understanding of infectious diseases and fosters the development of innovative interventions. Although not an open access journal, it provides a platform for high-quality research that influences policies and practices in the field. With an address located at 1155 16TH ST, NW, WASHINGTON, DC 20036, ACS Infectious Diseases is an authoritative voice in advancing the science and practice of infectious disease management.
INFECTION
Uncovering Breakthroughs in Microbiology and MedicineINFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.
Journal of Global Antimicrobial Resistance
Innovating strategies for a healthier future.The Journal of Global Antimicrobial Resistance, published by Elsevier Scientific Ltd, is a premier open access journal dedicated to addressing the critical issue of antimicrobial resistance on a global scale. Established in 2013 and significantly gaining traction as an open access platform since 2020, this journal serves as an essential resource for researchers, healthcare professionals, and policy makers invested in immunology, microbiology, and associated fields. With an impressive impact factor reflected through its consistent ranking in the Q2 category across multiple disciplines, including Microbiology and Immunology – where it ranks #29 out of 140 in Medical Microbiology – the journal ensures high-quality peer-reviewed articles that push the boundaries of current knowledge and practice. By offering a global perspective on research trends and public health implications, the Journal of Global Antimicrobial Resistance plays a pivotal role in advancing the scientific discourse necessary to combat the rising tide of antimicrobial resistance worldwide.
Infectious Diseases and Clinical Microbiology
Empowering healthcare through cutting-edge research insights.Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.
MIKROBIYOLOJI BULTENI
Fostering Knowledge in Immunology and MicrobiologyMIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.
Expert Review of Anti-Infective Therapy
Navigating the Frontiers of Infectious Disease SolutionsExpert Review of Anti-Infective Therapy, published by Taylor & Francis Ltd, is a leading journal in the field of infectious diseases, microbiology, and virology, boasting an impressive impact factor and ranking in the Q1 category across multiple disciplines. With an ISSN of 1478-7210 and E-ISSN 1744-8336, this journal has become a vital resource for researchers, professionals, and students aiming to advance their understanding of anti-infective therapies. Since its inception in 2003, the journal has provided critical insights, evidence-based reviews, and forward-thinking perspectives that contribute significantly to the ongoing efforts in combating infectious diseases. As of 2023, it ranks #36 out of 344 in Medicine/Infectious Diseases and maintains high percentiles in various other categories, reflecting its influence and reach within the scientific community. Although not an Open Access journal, its rich content is delivered through various academic libraries, sustaining its commitment to disseminating knowledge in the face of global health challenges. For those committed to innovation in the field, the Expert Review of Anti-Infective Therapy offers a platform that blends thorough research with practical applications, making significant strides in the fight against infectious pathogens.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Elevating Standards in Infectious Disease ResearchDIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.
Infection and Chemotherapy
Bridging Science and Clinical Practice in Infectious DiseasesInfection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.